JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB310054

Alexa Fluor® 647 Anti-DLL3 antibody [EPR22592-18]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal DLL3 antibody - conjugated to Alexa Fluor® 647.

View Alternative Names

Delta-like protein 3, Drosophila Delta homolog 3, Delta3, DLL3

  • 578 PE

    PE Anti-DLL3 antibody [EPR22592-18]

  • 660 APC

    APC Anti-DLL3 antibody [EPR22592-18]

  • HRP

    HRP Anti-DLL3 antibody [EPR22592-18]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-DLL3 antibody [EPR22592-18]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-DLL3 antibody [EPR22592-18]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-DLL3 antibody [EPR22592-18]

  • 603 Alexa Fluor® 568

    Alexa Fluor® 568 Anti-DLL3 antibody [EPR22592-18]

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-DLL3 antibody [EPR22592-18]

  • Unconjugated

    Anti-DLL3 antibody [EPR22592-18]

  • Carrier free

    Anti-DLL3 antibody [EPR22592-18] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR22592-18

Isotype

IgG

Conjugation

Alexa Fluor® 647

Excitation/Emission

Ex: 650nm, Em: 665nm

Carrier free

No

Applications

Antibody Labelling, Target Binding Affinity

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

The mouse recommendation is based on the IHC-P results. We do not guarantee WB for mouse.

style
left-column

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle|Store in the dark
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

DLL3 also known as Delta-like protein 3 is a member of the Delta/Serrate/Jagged family. This protein has a molecular mass of approximately 64 kDa. Scientists find DLL3 expression primarily in the Golgi apparatus of cells. In healthy tissues DLL3 is mostly present in the central nervous system whereas in abnormal conditions it appears in certain types of cancer cells. The detection of DLL3 expression commonly performed using IHC (immunohistochemistry) highlights its potential as a biomarker in pathological studies.
Biological function summary

DLL3 functions mainly in the modulation of the Notch signaling pathway. It does not activate this pathway but acts as an inhibitor blocking Notch ligand activation on adjacent cells. DLL3's role involves binding directly to Notch receptors altering cellular differentiation and growth processes. Despite being related to the Delta/Serrate/LAG-2 family DLL3 exhibits unique characteristics in its interactions forming part of a regulatory complex different from its family members.

Pathways

DLL3 engages importantly in the Notch signaling pathway affecting important cellular communications that regulate development and differentiation. Its interaction with proteins of the Notch family specifically the Notch receptors highlights its inhibitory role. Additionally DLL3 intersects with the Wnt signaling pathway though indirect influencing its output by modulating availability of pathway regulators.

DLL3 has significant implications in cancer notably small cell lung cancer (SCLC) and neuroendocrine tumors. Researchers associate increased DLL3 expression with aggressive tumor behavior and poor prognosis. The protein also shows relevance in congenital disorders such as spondylocostal dysostosis where abnormal DLL3 function leads to vertebral segmentation defects. In these contexts DLL3 often relates to proteins involved in the disruption of normal signaling cascades impacting both tumor progression and developmental anomalies.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Inhibits primary neurogenesis. May be required to divert neurons along a specific differentiation pathway. Plays a role in the formation of somite boundaries during segmentation of the paraxial mesoderm (By similarity).
See full target information DLL3
style
left-column
style
left-column
style
right-column

Complementary Products

Assay Kits

AB300312

Human DLL3 ELISA Kit

Recombinant|SimpleStep

Sandwich ELISA - Human DLL3 ELISA Kit (AB300312)

  • 0
  • 0
Primary Antibodies

AB275091

Anti-FGL1 antibody [EPR24018-27]

BOND RX™ Validated|RabMAb|Recombinant|20ul selling size

Flow Cytometry (Intracellular) - Anti-FGL1 antibody [EPR24018-27] (AB275091)

  • 0
  • 0
Primary Antibodies

AB77517

Anti-GPCR GPR87 antibody

Immunocytochemistry/ Immunofluorescence - Anti-GPCR GPR87 antibody (AB77517)

  • 0
  • 0
Primary Antibodies

AB205921

Anti-PD-L1 antibody [28-8]

BOND RX™ Validated|20ul selling size|Recombinant|KO Validated|Advanced Validation|RabMAb

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [28-8] (AB205921)

  • 4
  • 15
Primary Antibodies

AB230271

Anti-Hhip antibody

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Hhip antibody (AB230271)

  • 0
  • 1

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com